The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

[1]  C. Rosenfeld.  Microbiome Disturbances and Autism Spectrum Disorders , 2015, Drug Metabolism and Disposition.

[2]  E. Murphy,et al.  Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk , 2015, Current opinion in clinical nutrition and metabolic care.

[3]  M. Maes,et al.  The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue. , 2015, CNS & neurological disorders drug targets.

[4]  G. Oxenkrug.  Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes , 2015, Molecular Neurobiology.

[5]  T. Weir,et al.  Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.

[6]  M. Berk,et al.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders , 2015, BMC Medicine.

[7]  T. Scott,et al.  Xanthurenic acid is associated with higher insulin resistance and higher odds of diabetes , 2015 .

[8]  M. Carabotti,et al.  The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.

[9]  C. Lozupone,et al.  Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease , 2015, Microbial ecology in health and disease.

[10]  N. Talley,et al.  Pathways in gut-brain communication: Evidence for distinct gut-to-brain and brain-to-gut syndromes , 2015, The Australian and New Zealand journal of psychiatry.

[11]  M. Levings,et al.  The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome , 2015, Front. Immunol..

[12]  M. Bailey,et al.  Stress and the Commensal Microbiota: Importance in Parturition and Infant Neurodevelopment , 2015, Front. Psychiatry.

[13]  E. Shevach,et al.  Foxp3‐mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells , 2015, Journal of leukocyte biology.

[14]  M. Berk,et al.  The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases , 2015, Molecular Neurobiology.

[15]  Omry Koren,et al.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome , 2015, Nature.

[16]  T. Dinan,et al.  Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.

[17]  Michael Berk,et al.  The gut microbiome and diet in psychiatry: focus on depression , 2015, Current opinion in psychiatry.

[18]  Chang H. Kim,et al.  Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation , 2014, Immune network.

[19]  T. Dinan,et al.  Genomics of schizophrenia: time to consider the gut microbiome? , 2014, Molecular Psychiatry.

[20]  H. Tilg,et al.  Intestinal permeability – a new target for disease prevention and therapy , 2014, BMC Gastroenterology.

[21]  Michael Berk,et al.  Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome. , 2014, Neuro endocrinology letters.

[22]  J. Fechner,et al.  The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both , 2014, Front. Immunol..

[23]  David Padua,et al.  Altered brain‐gut axis in autism: Comorbidity or causative mechanisms? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  T. Kishimoto,et al.  Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research , 2014, Front. Immunol..

[25]  D. Ditor,et al.  The common inflammatory etiology of depression and cognitive impairment: a therapeutic target , 2014, Journal of Neuroinflammation.

[26]  Michael Berk,et al.  Oxidative & nitrosative stress in depression: Why so much stress? , 2014, Neuroscience & Biobehavioral Reviews.

[27]  F. Montecucco,et al.  Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes , 2014, Mediators of inflammation.

[28]  G. Frost,et al.  The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents , 2014, International Journal of Obesity.

[29]  S. Collins,et al.  The microbiota–gut–brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? , 2014, The Journal of physiology.

[30]  Yuko Sakurai,et al.  Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes , 2014, Diabetes Care.

[31]  M. Nieuwdorp,et al.  Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus , 2014, Clinical and experimental immunology.

[32]  S. Eussen,et al.  Evidence for increased catabolism of vitamin B-6 during systemic inflammation. , 2014, The American journal of clinical nutrition.

[33]  G. Lesinski,et al.  Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling , 2014, Cancer Immunology, Immunotherapy.

[34]  T. Dinan,et al.  Minireview: Gut microbiota: the neglected endocrine organ. , 2014, Molecular endocrinology.

[35]  S. Kang,et al.  Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway , 2014, Mucosal Immunology.

[36]  R. Shulman,et al.  Brain-gut microbiome interactions and functional bowel disorders. , 2014, Gastroenterology.

[37]  M. Angley,et al.  Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders. , 2014, Biomarkers in medicine.

[38]  M. Bailey,et al.  Impact of stressor exposure on the interplay between commensal microbiota and host inflammation , 2014, Gut microbes.

[39]  Qing Li,et al.  The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. , 2014, Human immunology.

[40]  A. Rosendahl,et al.  Macrophage Contact Dependent and Independent TLR4 Mechanisms Induce β-Cell Dysfunction and Apoptosis in a Mouse Model of Type 2 Diabetes , 2014, PloS one.

[41]  A. Haslberger,et al.  Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. , 2014, Gene.

[42]  M. Maes,et al.  Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala , 2014, Current neuropharmacology.

[43]  D. Lio,et al.  Role of TGF-β Pathway Polymorphisms in Sporadic Thoracic Aortic Aneurysm: rs900 TGF-β2 Is a Marker of Differential Gender Susceptibility , 2014, Mediators of inflammation.

[44]  J. Karn,et al.  Short-Chain Fatty Acids from Periodontal Pathogens Suppress Histone Deacetylases, EZH2, and SUV39H1 To Promote Kaposi's Sarcoma-Associated Herpesvirus Replication , 2014, Journal of Virology.

[45]  Huidong Shi,et al.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. , 2014, Immunity.

[46]  R. Medzhitov,et al.  The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition , 2014, Proceedings of the National Academy of Sciences.

[47]  I. Kaji,et al.  Short-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release , 2014, Digestion.

[48]  J. Cryan,et al.  Microbial genes, brain & behaviour – epigenetic regulation of the gut–brain axis , 2014, Genes, brain, and behavior.

[49]  D. Fuchs,et al.  Obesity‐related dysregulation of the Tryptophan–Kynurenine metabolism: Role of age and parameters of the metabolic syndrome , 2014, Obesity.

[50]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[51]  G. Morris,et al.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome , 2013, Metabolic Brain Disease.

[52]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[53]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[54]  J. Hoffman,et al.  Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.

[55]  G. Oxenkrug,et al.  Kynurenines and vitamin B6: link between diabetes and depression. , 2013, Journal of bioinformatics and diabetes.

[56]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[57]  Liang Zhou,et al.  Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. , 2013, Immunity.

[58]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[59]  J. Hoffman,et al.  Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.

[60]  M. Yanagisawa,et al.  Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. , 2013, Gastroenterology.

[61]  Joshua LaBaer,et al.  Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children , 2013, PloS one.

[62]  I. Soares,et al.  Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor‐reactive effect of peripheral blood mononuclear cells , 2013, Cell biochemistry and function.

[63]  G. Bhat,et al.  Kynurenine 3‐monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands , 2013, European journal of immunology.

[64]  G. Oxenkrug.  Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways , 2013, Molecular Neurobiology.

[65]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[66]  N. Musi,et al.  Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle , 2013, PloS one.

[67]  Y. Benno,et al.  Cerebral Low-Molecular Metabolites Influenced by Intestinal Microbiota: A Pilot Study , 2013, Front. Syst. Neurosci..

[68]  Patrice D Cani,et al.  Diabetes, obesity and gut microbiota. , 2013, Best practice & research. Clinical gastroenterology.

[69]  Nicholas Stoy,et al.  An expanding range of targets for kynurenine metabolites of tryptophan. , 2013, Trends in pharmacological sciences.

[70]  U. Sundaram,et al.  Monocarboxylate 4 Mediated Butyrate Transport in a Rat Intestinal Epithelial Cell Line , 2013, Digestive Diseases and Sciences.

[71]  Min Zhang,et al.  Butyrate increases IL-23 production by stimulated dendritic cells. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[72]  T. Dinan,et al.  Communication between gastrointestinal bacteria and the nervous system. , 2012, Current opinion in pharmacology.

[73]  S. Cox,et al.  Molecular Characterisation of Gastrointestinal Microbiota of Children With Autism (With and Without Gastrointestinal Dysfunction) and Their Neurotypical Siblings , 2012, Autism research : official journal of the International Society for Autism Research.

[74]  J. Bienenstock,et al.  On communication between gut microbes and the brain , 2012, Current opinion in gastroenterology.

[75]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[76]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[77]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[78]  D. Macfabe,et al.  Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders , 2012, Microbial ecology in health and disease.

[79]  M. Bailey.  The contributing role of the intestinal microbiota in stressor-induced increases in susceptibility to enteric infection and systemic immunomodulation , 2012, Hormones and Behavior.

[80]  H. Spits,et al.  Transcriptional control of innate lymphoid cells , 2012, European journal of immunology.

[81]  P. O’Toole,et al.  γ‐Aminobutyric acid production by culturable bacteria from the human intestine , 2012, Journal of applied microbiology.

[82]  R. Frye.  Biomarkers of Abnormal Energy Metabolism in Children with Autism Spectrum Disorder , 2012 .

[83]  P. Rosenstiel,et al.  ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation , 2012, Nature.

[84]  D. Macfabe,et al.  The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders , 2012, Journal of Neuroinflammation.

[85]  E. Benjamin,et al.  Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. , 2012, The Journal of nutrition.

[86]  Patrice D Cani.  Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[87]  M. Mohty,et al.  Impact of valproic acid on dendritic cells function. , 2012, Immunobiology.

[88]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[89]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[90]  D. C. Cara,et al.  Oral Supplementation of Butyrate Reduces Mucositis and Intestinal Permeability Associated with 5-Fluorouracil Administration , 2012, Lipids.

[91]  Takafumi Hara,et al.  Short‐chain fatty acid receptor GPR41‐mediated activation of sympathetic neurons involves synapsin 2b phosphorylation , 2012, FEBS letters.

[92]  T. Dinan,et al.  Su1992 Regulation of Serotonergic Neurotransmission and Behaviour by the Brain-Gut-Microbiome Axis , 2012 .

[93]  W. Rief,et al.  Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway , 2012, Psychiatry Research.

[94]  M. Kotb,et al.  Etiology of autistic features: the persisting neurotoxic effects of propionic acid , 2012, Journal of Neuroinflammation.

[95]  S. Finegold,et al.  Microbiology of regressive autism. , 2012, Anaerobe.

[96]  Lei Li,et al.  The two-step biotransformation of monosodium glutamate to GABA by Lactobacillus brevis growing and resting cells , 2012, Applied Microbiology and Biotechnology.

[97]  F. Guerini,et al.  Vitamin D Receptor Gene Polymorphisms and HLA DRB1*04 Cosegregation in Saudi Type 2 Diabetes Patients , 2012, The Journal of Immunology.

[98]  Yong Zhao,et al.  The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications , 2012, Journal of Molecular Medicine.

[99]  Liang Zhou,et al.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. , 2012, Immunity.

[100]  A. M. Habib,et al.  Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 , 2012, Diabetes.

[101]  Tanmay Parekh,et al.  Application of Novel PCR-Based Methods for Detection, Quantitation, and Phylogenetic Characterization of Sutterella Species in Intestinal Biopsy Samples from Children with Autism and Gastrointestinal Disturbances , 2012, mBio.

[102]  S. Finegold.  State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. , 2011, Anaerobe.

[103]  Natalie A. Roberts,et al.  Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation , 2011, Cell.

[104]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[105]  John F. Cryan,et al.  Brain–Gut–Microbe Communication in Health and Disease , 2011, Front. Physio..

[106]  J. Doré,et al.  Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept , 2011, Diabetologia.

[107]  Jacques Schrenzel,et al.  Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice , 2011, Diabetes.

[108]  W. Lipkin,et al.  Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances , 2011, PloS one.

[109]  P. Sansonetti,et al.  Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment , 2011, EMBO molecular medicine.

[110]  R. Curi,et al.  Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. , 2011, The Journal of nutritional biochemistry.

[111]  S. Finegold.  Desulfovibrio species are potentially important in regressive autism. , 2011, Medical hypotheses.

[112]  A. Bar-Or,et al.  TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function , 2011, The Journal of Immunology.

[113]  Markus P. Schlaich,et al.  Change in Sympathetic Nerve Firing Pattern Associated with Dietary Weight Loss in the Metabolic Syndrome , 2011, Front. Physio..

[114]  P. François,et al.  Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue , 2011, Front. Microbio..

[115]  P. Hawkins,et al.  SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor , 2011, PloS one.

[116]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[117]  B. Leonard,et al.  The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[118]  Takafumi Hara,et al.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) , 2011, Proceedings of the National Academy of Sciences.

[119]  U. Grohmann,et al.  Indoleamine 2,3‐dioxygenase: From catalyst to signaling function , 2012, European journal of immunology.

[120]  P. Ueland,et al.  Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. , 2011, The Journal of nutrition.

[121]  W. D. de Vos,et al.  Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[122]  James B. Adams,et al.  Gastrointestinal flora and gastrointestinal status in children with autism -- comparisons to typical children and correlation with autism severity , 2011, BMC gastroenterology.

[123]  J. Foster,et al.  Reduced anxiety‐like behavior and central neurochemical change in germ‐free mice , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[124]  S. Dowd,et al.  Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation , 2011, Brain, Behavior, and Immunity.

[125]  H. M. Garay-Malpartida,et al.  Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis , 2011, BMC Immunology.

[126]  H. Forssberg,et al.  Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.

[127]  V. Salomaa,et al.  Endotoxemia Is Associated With an Increased Risk of Incident Diabetes , 2011, Diabetes Care.

[128]  W. Jackson,et al.  Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. , 2010, Gastroenterology.

[129]  M. Maa,et al.  Butyrate reduced lipopolysaccharide-mediated macrophage migration by suppression of Src enhancement and focal adhesion kinase activity. , 2010, The Journal of nutritional biochemistry.

[130]  Kazuya Masuda,et al.  Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism , 2010, Proceedings of the National Academy of Sciences.

[131]  E. Murphy,et al.  Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models , 2010, Gut.

[132]  Carmela Bravaccio,et al.  Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives , 2010, Journal of pediatric gastroenterology and nutrition.

[133]  J. Fechner,et al.  An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.

[134]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[135]  R. Bernier,et al.  Neurobiological correlates of social functioning in autism. , 2010, Clinical psychology review.

[136]  Eunseog Youn,et al.  Pyrosequencing study of fecal microflora of autistic and control children. , 2010, Anaerobe.

[137]  F. Bäckhed,et al.  The endocannabinoid system links gut microbiota to adipogenesis , 2010, Molecular systems biology.

[138]  N. Lambert,et al.  Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone Deacetylases , 2010, The Journal of Biological Chemistry.

[139]  S. Ross,et al.  Incretin agents in type 2 diabetes. , 2010, Canadian family physician Medecin de famille canadien.

[140]  M. Cawthorne,et al.  Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids , 2010, FEBS letters.

[141]  G. Oxenkrug.  Metabolic syndrome, age‐associated neuroendocrine disorders, and dysregulation of tryptophan—kynurenine metabolism , 2010, Annals of the New York Academy of Sciences.

[142]  A. Abdulamir,et al.  The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects , 2010, The open biochemistry journal.

[143]  M. Dijkstra,et al.  Regulation of adipokine production in human adipose tissue by propionic acid , 2010, European journal of clinical investigation.

[144]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[145]  F. Barale,et al.  Low-grade endotoxemia in patients with severe autism , 2010, Neuroscience Letters.

[146]  S. Narumiya,et al.  Prostaglandin E2, an immunoactivator. , 2010, Journal of pharmacological sciences.

[147]  G. Musso,et al.  Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders , 2010, Current opinion in lipidology.

[148]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[149]  C. Leung,et al.  Butyrate mediates nucleotide‐binding and oligomerisation domain (NOD) 2‐dependent mucosal immune responses against peptidoglycan , 2009, European journal of immunology.

[150]  P. Rosenstiel,et al.  G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation1 , 2009, The Journal of Immunology.

[151]  F. Monsma,et al.  Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. , 2009 .

[152]  R. Curi,et al.  Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. , 2009, Clinical science.

[153]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[154]  T. Wolever,et al.  Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α , 2009, British Journal of Nutrition.

[155]  V. A. Shishov,et al.  Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12 , 2009, Applied Biochemistry and Microbiology.

[156]  Ian R. Holzman,et al.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. , 2009, The Journal of nutrition.

[157]  H. Herfarth,et al.  Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility , 2009, PloS one.

[158]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[159]  S. Narumiya,et al.  Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion , 2009, Nature Medicine.

[160]  R. Akers,et al.  Identification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes. , 2009, Journal of dairy science.

[161]  I. Kato,et al.  Expression of short-chain fatty acid receptor GPR41 in the human colon. , 2009, Biomedical research.

[162]  M. Naruszewicz,et al.  Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[163]  P. Scully,et al.  Kynurenine pathway in psychosis: evidence of increased tryptophan degradation , 2009, Journal of psychopharmacology.

[164]  Bernard Henrissat,et al.  Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla , 2009, Proceedings of the National Academy of Sciences.

[165]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[166]  D. Drucker,et al.  Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse. , 2009, Endocrinology.

[167]  B. Evers,et al.  QS296. Toll-Like Receptor 4 Activation in Human Colorectal Cancer Cells Induces PI3K/AKT Signaling , 2009 .

[168]  M. Veldhoen,et al.  Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells , 2009, The Journal of experimental medicine.

[169]  Leigh A. Stoddart,et al.  International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions , 2008, Pharmacological Reviews.

[170]  D. Schrenk,et al.  Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. , 2008, The Journal of nutritional biochemistry.

[171]  Yang Li,et al.  Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. , 2008, Endocrinology.

[172]  T. Connor,et al.  Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ? , 2008, Neuroscience Letters.

[173]  G. Adema,et al.  Toll‐like receptor signalling on Tregs: to suppress or not to suppress? , 2008, Immunology.

[174]  A. Barnett,et al.  Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance , 2008, International journal of clinical practice.

[175]  D. Talwar,et al.  Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness. , 2008, The American journal of clinical nutrition.

[176]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[177]  D. Cain,et al.  Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism , 2008, Neuropharmacology.

[178]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[179]  M. Maes,et al.  The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. , 2008, Neuro endocrinology letters.

[180]  J. Parsons,et al.  Regulation of lamellipodial persistence, adhesion turnover, and motility in macrophages by focal adhesion kinase , 2007, The Journal of cell biology.

[181]  M. Maes,et al.  The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. , 2007, Neuro endocrinology letters.

[182]  P. Gean,et al.  Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity , 2007, Neuroscience.

[183]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[184]  C. Yanofsky,et al.  RNA-based regulation of genes of tryptophan synthesis and degradation, in bacteria. , 2007, RNA.

[185]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[186]  D. Chuang,et al.  Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action , 2007, Journal of Pharmacology and Experimental Therapeutics.

[187]  H. Yamashita,et al.  Improvement of Obesity and Glucose Tolerance by Acetate in Type 2 Diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats , 2007, Bioscience, biotechnology, and biochemistry.

[188]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[189]  E. Seidman,et al.  Dual effect of butyrate on IL-1beta--mediated intestinal epithelial cell inflammatory response. , 2007, DNA and cell biology.

[190]  Gary W Miller,et al.  Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease , 2007, Journal of neurochemistry.

[191]  D. Carretta,et al.  Propionate induces pH(i) changes through calcium flux, ERK1/2, p38, and PKC in bovine neutrophils. , 2007, Veterinary immunology and immunopathology.

[192]  Francis Boon,et al.  Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders , 2007, Behavioural Brain Research.

[193]  R. Gill,et al.  Induction of Indoleamine 2,3-Dioxygenase by Interferon-γ in Human Islets , 2007, Diabetes.

[194]  Soonkyu Chung,et al.  Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. , 2006, Endocrinology.

[195]  B. Nankova,et al.  Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein , 2006, Brain Research.

[196]  R. Rodenburg,et al.  Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. , 2006, The Biochemical journal.

[197]  R. Cavalli,et al.  Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells , 2006, British journal of pharmacology.

[198]  Yoshifumi Oshima,et al.  Dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet , 2006, British Journal of Nutrition.

[199]  R. Enriquez,et al.  Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity , 2006, Diabetologia.

[200]  W. Griffin,et al.  Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.

[201]  E. Seto,et al.  Acetylation and deacetylation of non-histone proteins. , 2005, Gene.

[202]  B. Nankova,et al.  Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. , 2005, Brain research. Molecular brain research.

[203]  R. Alon,et al.  Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.

[204]  Hee-Sun Kim,et al.  Repression of interferon-γ-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways , 2005, Journal of Neuroimmunology.

[205]  Xue Ming,et al.  Reduced cardiac parasympathetic activity in children with autism , 2005, Brain and Development.

[206]  Anne L McCartney,et al.  Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. , 2005, Journal of medical microbiology.

[207]  L. Pellerin.  How astrocytes feed hungry neurons , 2005, Molecular Neurobiology.

[208]  Luc Pellerin,et al.  Monocarboxylate transporters in the central nervous system: distribution, regulation and function , 2005, Journal of neurochemistry.

[209]  W. Faulk,et al.  Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. , 2005, Nutrition.

[210]  O. Inatomi,et al.  Butyrate blocks interferon-γ-inducible protein-10 release in human intestinal subepithelial myofibroblasts , 2005, Journal of Gastroenterology.

[211]  J. Neu,et al.  Tight junctions, leaky intestines, and pediatric diseases , 2005, Acta paediatrica.

[212]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[213]  P. Filipek,et al.  Relative Carnitine Deficiency in Autism , 2004, Journal of autism and developmental disorders.

[214]  S. Finegold,et al.  Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children , 2004, Applied and Environmental Microbiology.

[215]  M. Wajner,et al.  The role of oxidative damage in the neuropathology of organic acidurias: Insights from animal studies , 2004, Journal of Inherited Metabolic Disease.

[216]  Y. Chida,et al.  Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice , 2004, The Journal of physiology.

[217]  Tonya Clark-Taylor,et al.  Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. , 2004, Medical hypotheses.

[218]  D. Drucker,et al.  Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. , 2004, Endocrinology.

[219]  M. Kaczmarczyk,et al.  Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-κB and PPARα , 2004 .

[220]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids , 2004, British journal of pharmacology.

[221]  M. Neumann,et al.  Butyrate Inhibits Leukocyte Adhesion to Endothelial Cells via Modulation of VCAM-1 , 2004, Inflammatory bowel diseases.

[222]  R. Kedzierski,et al.  Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[223]  R. Duelli,et al.  Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain , 2004, Neuroscience Letters.

[224]  O. Ottersen,et al.  Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain , 2003, Neuroscience.

[225]  V. Pieribone,et al.  Midbrain serotonergic neurons are central pH chemoreceptors , 2003, Nature Neuroscience.

[226]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[227]  B. Olde,et al.  Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. , 2003, Biochemical and biophysical research communications.

[228]  Masataka Harada,et al.  Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 , 2003, Nature.

[229]  C. Jobin,et al.  Butyrate modulates intestinal epithelial cell‐mediated neutrophil migration , 2003, Clinical and experimental immunology.

[230]  Haroun Shah,et al.  Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[231]  B. Hinnebusch,et al.  The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. , 2002, The Journal of nutrition.

[232]  A. Jaeschke,et al.  Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.

[233]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[234]  S. Nakaji,et al.  Effect of sodium butyrate on reactive oxygen species generation by human neutrophils. , 2001, Scandinavian journal of gastroenterology.

[235]  M. M. Mu,et al.  The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells , 2000, Journal of endotoxin research.

[236]  R. Macdermott,et al.  Molecular Medicine © 1999 The Picower Institute Press Butyrate Switches the Pattern of Chemokine Secretion by Intestinal Epithelial Cells through , 2022 .

[237]  H. Hara,et al.  Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. , 1999, The Journal of nutrition.

[238]  V. Korchin,et al.  Diabetogenic activity of xanturenic acid determined by its chelating properties? , 1998, Transplantation proceedings.

[239]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[240]  S. Katznelson,et al.  Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function. , 1998, The Journal of surgical research.

[241]  H. Sugiya,et al.  PROPIONIC ACID STIMULATES SUPEROXIDE GENERATION IN HUMAN NEUTROPHILS , 1998, Cell biology international.

[242]  M. Säemann,et al.  n‐Butyrate downregulates the stimulatory function of peripheral blood‐derived antigen‐presenting cells: a potential mechanism for modulating T‐cell responses by short‐chain fatty acids , 1997, Immunology.

[243]  F. Luscinskas,et al.  L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro. , 1997, Journal of immunology.

[244]  J. Cuber,et al.  Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. , 1996, The Journal of endocrinology.

[245]  P. D'eufemia,et al.  Abnormal intestinal permeability in children with autism , 1996, Acta paediatrica.

[246]  C. Hart,et al.  Sodium butyrate delays neutrophil apoptosis: role of protein biosynthesis in neutrophil survival , 1996, British journal of haematology.

[247]  C. Morand,et al.  Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes , 1995, British Journal of Nutrition.

[248]  P. Gibson,et al.  Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. , 1993, Gut.

[249]  R. Yuste,et al.  Extensive dye coupling between rat neocortical neurons during the period of circuit formation , 1993, Neuron.

[250]  E. Brass.  Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability. , 1992, The Journal of nutrition.

[251]  D. Jenkins,et al.  Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. , 1991, The American journal of clinical nutrition.

[252]  M. Kimoto,et al.  Accumulation of 3-hydroxy-L-kynurenine sulfate and ethanolamine in urine of the rat injected with 1-aminoproline. , 1991, The Tokushima journal of experimental medicine.

[253]  James W. Anderson,et al.  Propionate Inhibits Hepatocyte Lipid Synthesis , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[254]  R. Caprilli,et al.  Fecal lactate and ulcerative colitis. , 1988, Gastroenterology.

[255]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[256]  Y. Kotake,et al.  Urinary excretion of xanthurenic acid and zinc in diabetes: (3). Occurrence of xanthurenic acid-Zn2+ complex in urine of diabetic patients and of experimentally-diabetic rats. , 1986, The Italian journal of biochemistry.

[257]  K. S. Rogers,et al.  3-Hydroxykynurenine, 3-Hydroxyanthranilic Acid, and o-Aminophenol Inhibit Leucine-Stimulated Insulin Release from Rat Pancreatic Islets , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[258]  R. Obeid,et al.  Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. , 2015, Diabetes research and clinical practice.

[259]  T. Dinan,et al.  Microbiota regulation of the Mammalian gut-brain axis. , 2015, Advances in applied microbiology.

[260]  T. Dinan,et al.  The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. , 2014, Advances in experimental medicine and biology.

[261]  H. Savelkoul,et al.  Immune dysregulation in autism spectrum disorder , 2013, European Journal of Pediatrics.

[262]  Antonio Calignano,et al.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. , 2011, World journal of gastroenterology.

[263]  Lauren L. Jones,et al.  Acylcarnitines: role in brain. , 2010, Progress in lipid research.

[264]  F. Monsma,et al.  Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. , 2009, World journal of gastroenterology.

[265]  E. Olson,et al.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.

[266]  Athena,et al.  G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation , 2009 .

[267]  A. Luca,et al.  IL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi , 2008 .

[268]  R. Gill,et al.  Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets. , 2007, Diabetes.

[269]  M. Trushin,et al.  MULTIPLE SCLEROSIS AND NEUROCHEMICAL DISTURBANCES , 2007 .

[270]  稲富 理.  Butyrate blocks interferon-γ-inducible protein-10 release in human intestinal subepithelial myofibroblasts , 2006 .

[271]  J. Boyle,et al.  Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. , 2005, Current vascular pharmacology.

[272]  Hee-Sun Kim,et al.  Repression of interferon-gamma-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways. , 2005, Journal of neuroimmunology.

[273]  T. Ueda,et al.  Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA). , 1975, Acta vitaminologica et enzymologica.

[274]  A. D. Russell,et al.  The inclusion of antimicrobial agents in pharmaceutical products. , 1967, Advances in applied microbiology.